Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial

Feline P. B. Kroon*, Marion C. Kortekaas, Annelies Boonen, Stefan Bohringer, Monique Reijnierse, Frits R. Rosendaal, Naghmeh Riyazi, Mirian Starmans, Franktien Turkstra, Jende van Zeben, Cornelia F. Allaart, Margreet Kloppenburg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1993-2001
Number of pages9
JournalLancet
Volume394
Issue number10213
DOIs
Publication statusPublished - 6 Dec 2019

Keywords

  • NONSTEROIDAL ANTIINFLAMMATORY DRUGS
  • INDUCED OSTEOPOROSIS
  • CRITERIA
  • RISK

Cite this

Kroon, F. P. B., Kortekaas, M. C., Boonen, A., Bohringer, S., Reijnierse, M., Rosendaal, F. R., Riyazi, N., Starmans, M., Turkstra, F., van Zeben, J., Allaart, C. F., & Kloppenburg, M. (2019). Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial. Lancet, 394(10213), 1993-2001. https://doi.org/10.1016/S0140-6736(19)32489-4